Search Results

RegMedNet’s 2023 remix: top content of the year – RegMedNet

RegMedNet's 2023 remix: top content of the year   RegMedNet

Cell Based Assay & High Content Screening Market Report 2021: The Workhorse of the Pharmaceutical Industry is Becoming a Central Player in…

DUBLIN, Oct. 4, 2021 /PRNewswire/ -- The "Cell Based Assay & High Content Screening Markets" report has been added to ResearchAndMarkets.com's offering.

Dale Toney: A ‘wake up call’ for diabetes talk to your doctor about prevention and treatment – User-generated content

An estimated 88 million Americans have prediabetes, and just over 1 in 10 have been diagnosed with type 2 diabetes.

Bone Marrow Processing System Market: Segmental Highlights and Table of Content 2025 – NeighborWebSJ

Bone marrow aspiration and trephine biopsy are usually performed on the back of the hipbone, or posterior iliac crest. An aspirate can also be obtained from the sternum (breastbone). For the sternal aspirate, the patient lies on their back, with a pillow under the shoulder to raise the chest

Global Cell Based Assay & High Content Screening Markets to 2024: Updated Report – Understand Growth Expectations and the Potential Market Size -…

DUBLIN--(BUSINESS WIRE)--The "Cell Based Assay & High Content Screening Markets Market Forecasts by Application, With Executive and Consultant Guides and including Customized Forecasting and Analysis 2020 to 2024" report has been added to ResearchAndMarkets.com's offering.

Covington-based CTI partners with Humanigen for study of Lenzilumab for treatment of Coronavirus – User-generated content

Covington-based CTIClinical Trial and Consulting Services has partnered with California-based Humanigen, Inc. on a study for the treatment of novel coronavirus 2019 (COVID-19). Humanigen, Inc., (HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the companys proprietary Humaneered anti-human-granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody, announced that the company has submitted an initial protocol synopsis to the FDA in support of the companys plans to initiate a multi-center, US, Phase III study in COVID-19 patients.

Art Lander’s Outdoors: Although rare at backyard bird feeders, the Eastern Towhee is common in Ky. – User-generated content

Eastern Towhee (Photo by Brian Kushner, Audubon Society) Editors Note: This is the tenth article in an occasional series about backyard birds. The Eastern Towhee (Pipilo erythrophthalmus) is an infrequent visitor to backyard bird feeders. Consider yourself lucky to see this large sparrow, with distinctive plumage, feeding on the ground beneath one of your hanging feeders during the late winter or early spring.

Healthy Headlines: Four common myths about genetic testing and why they are not accurate – User-generated content

St. Elizabeth Healthcare If you could take a simple test that would identify your risks of developing a potentially deadly disease so you could prevent it or treat it sooner, wouldnt you?

Healthy Headlines: Breast cancer genetic testing: What you need to know to make an informed decision – User-generated content

St. Elizabeth Healthcare At St.

Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers content= – PR Newswire UK

NetworkNewsWire Editorial Coverage NEW YORK, Sept.

Minuscule nanostraws sample a cell’s contents without damage … – Stanford University News

Cells within our bodies divide and change over time, with thousands of chemical reactions occurring within each cell daily. This makes it difficult for scientists to understand whats happening inside. Now, tiny nanostraws developed by Stanford researchers offer a method of sampling cell contents without disrupting its natural processes.

“Leading Edge” Set to Produce New Content Featuring Stem Cell Therapy, with Host Jimmy Johnson

(PRWEB) December 21, 2013 Stem cell therapy has a tremendous potential to cure various illnesses and injuries.

"Leading Edge" Set to Produce New Content Featuring Stem Cell Therapy, with Host Jimmy Johnson

(PRWEB) December 21, 2013 Stem cell therapy has a tremendous potential to cure various illnesses and injuries. Recent news items have highlighted possibilities that it could treat damaged spinal cords or revitalize hip joints.

5 personality traits employers should look for in a job applicant's social media content

Public release date: 8-Oct-2013 [ | E-mail | Share ] Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, October 8, 2013Job applicants try to make a good impression when meeting a prospective employer, but employers may be able to learn what applicants are really like by screening their social media posts. Unfiltered personal communications, photos, comments about others, and references to alcohol and drug use reflect five revealing personality characteristics that might impact their work performance, according to an article in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers

For New York Times readers, fairness matters when it comes to paying for content

Public release date: 31-Oct-2012 [ | E-mail | Share ] Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, October 31, 2012In a paper published today by Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, researchers found that New York Times readers who were led to believe the newspaper's paywall was motivated by financial need were generally supportive and willing to pay, while those who believed it was motivated by profit were generally unsupportive and unwilling to pay. The article "Paying for What Was Free: Lessons from the New York Times Paywall," written by Jonathan Cook, Associate Research Scientist in the Department of Psychology at Columbia University, and Shahzeen Attari, Assistant Professor in the School of Public and Environmental Affairs (SPEA) at Indiana University-Bloomington is available free on the Cyberpsychology, Behavior, and Social Networking website

Illumina Launches TruSightTM Targeted Sequencing Content Sets

SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (ILMN) today announced five initial TruSight content sets for use in next-generation sequencing (NGS) in laboratory settings. Designed by recognized experts at leading institutions, the content sets offer cost-effective, streamlined, targeted sequencing for specific genetic diseases or conditions.

JCI early table of contents for March 12, 2012

Public release date: 12-Mar-2012 [ | E-mail | Share ] Contact: Sarah Jackson press_releases@the-jci.org 919-684-0620 Journal of Clinical Investigation EDITOR'S PICK Restoring what's lost: uncovering how liver tissue regenerates The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal. Laurie DeLeve and her colleagues at the University of Southern California in Los Angeles wanted to better understand which cells are specifically responsible for driving liver regeneration.

JCI early table of contents for March 12, 2012

Public release date: 12-Mar-2012 [ | E-mail | Share ] Contact: Sarah Jackson press_releases@the-jci.org 919-684-0620 Journal of Clinical Investigation EDITOR'S PICK Restoring what's lost: uncovering how liver tissue regenerates The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal. Laurie DeLeve and her colleagues at the University of Southern California in Los Angeles wanted to better understand which cells are specifically responsible for driving liver regeneration.

The Chosen Child — Screening Genetic Content

Genetic research involving human embryos has been a sensitive area of investigation.

Pioneering CRISPR Gene Editing Trial: 79% of Participants See Improvement – SciTechDaily

A clinical trial utilizing CRISPR-based gene editing demonstrated promising results, with approximately 79% of participants showing improvement in a rare form of blindness caused by a mutation in the CEP290 gene. The study, published in the New England Journal of Medicine, marks a significant step in using gene editing to treat inherited retinal diseases

Mesenchymal Stem Cells Market to Witness an Outstanding Growth by 2030 – openPR

Mesenchymal Stem Cells Market Major Highlights of TOC: Chapter 1: Overview of the Global Mesenchymal Stem Cells Market in 2024 1.1 GREEN HYDROGEN Industry Analysis 1.2 Key Companies and Product Profiles 1.3 Mesenchymal Stem Cells Market Segments 1.4 Industry Value Chain Analysis 1.5 Market Dynamics- Trends, Drivers, and Opportunities 1.6 Pricing Analysis 1.7 Porter's Five Forces Analysis 1.8 SWOT Profile 1.9 Macro-Economic and Demographic Impact Analysis 1.10 Scenario Analysis Chapter 2: Global GREEN HYDROGEN Demand Forecasts 2.1 Overview of the Segment 2.2 Global Historic Mesenchymal Stem Cells Market Size (2018-2023) by Types, Applications, and Other Segments 2.3 Global Forecast Mesenchymal Stem Cells Market Size (2024-2030) by Types, Applications, and Other Segments Chapter 3: Segment-wise Mesenchymal Stem Cells Market Forecasts 3.1 Key Market Segments 3.2 Premium Insights- Largest Types, Applications and Segments 3.3 Premium Insights- Most Lucrative Types, Applications, and Segments Chapter 4: Mesenchymal Stem Cells Market Outlook by Country 4.1 Mesenchymal Stem Cells Market by Regions 4.2 Mesenchymal Stem Cells Market Revenue Share by Region 4.3 North America (US, Canada, Mexico) 4.4 Europe (Germany, UK, France, Spain, Italy, Russia, Others) 4.5 Asia Pacific (China, Japan, India, South Korea, Australia, South East Asia, Others) 4.6 Latin America (Brazil, Argentina, Chile, Others) 4.7 Middle East and Africa (Saudi Arabia, UAE, Qatar, South Africa, Nigeria, Egypt, Others) Player Analysis in Chapter Five 5.1 Players' Market Share Analysis (2023) 5.2 Regional Market Concentration Rates 5.3 Business Profiles, SWOT Analysis, Financial Details, Product Portfolio of Companies ..........continued For a comprehensive competitive analysis, Buy this report now and gain access to a detailed table of contents @ https://www.usdanalytics.com/payment/report-9048 Why should you purchase this report? USD Analytics offers essential historical and analytical data on the global Mesenchymal Stem Cells Market. The report thoroughly evaluates future market trends and potential changes in market behavior.

Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi … – Nature.com

Derivation of HOs from hiPSCs We previously generated hiPSC-derived cardiac organoids (COs), and the CO formation resulted in the enhanced maturity of hiPSC-derived cardiomyocytes [18].

Mesenchymal stem cells pretreated with interferon-gamma attenuate renal fibrosis by enhancing regulatory T cell … – Nature.com

Cell culture Human MSCs from bone marrow were purchased from Riken BioResource Research Center (Ibaraki, Japan)and cultured in Dulbeccos Modified Eagles Medium (DMEM: Sigma-Aldrich, St.

$6.2 million to help develop gene therapy for HIV Washington University School of Medicine in St. Louis – Washington University School of Medicine in…

Visit the News Hub Genetically engineered B cells could produce super-antibodies to HIV Researchers at Washington University School of Medicine in St.

Gene Therapy is Having its Moment: Can the Clinical Research Ecosystem Seize It? – Contract Pharma

Gene therapy research is booming.

Archives
-->